Resmed INC RESMED ORD SHS
Resmed INC RESMED ORD SHS/ US7611521078 /
0KW4
|
07/11/2024 16:35:22
|
Chg.
+0.40
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
244.41USD
|
+0.16%
|
367
Turnover: 89,708.97 |
-Bid Size: - |
-Ask Size: - |
35.87 bill.USD |
0.79% |
35.20 |
Business description
ResMed (NYSE:RMD) changes lives with award-winning medical devices and cutting-edge cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 1 million patients remotely monitored every day.
Management board & Supervisory board
| CEO |
| Michael J. Farrell |
| Management board |
| Brett Sandercock, Rob Douglas, Lucile Blaise, Bobby Ghoshal, Katrin Pucknat, Justin Leong, Dawn Haake, Vered Keisar, Carlos M. Nunez, Andrew Price, Hemanth Reddy, Michael Rider, Urvashi Tyagi, Amy Wakeham |
| Supervisory board |
| Michael Farrell, Carol J. Burt, Harjit Gill, Jan De Witte, Karen Drexler, Richard Sulpizio, Ronald Taylor, John Hernandez, Desney Tan, Dr. Peter C. Farrell |
Company data
| Name: |
ResMed Inc. |
| Address: |
9001 Spectrum Center Blvd.,San Diego, California 92123, USA |
| Phone: |
+1-858-836-5000 |
| Fax: |
+1-858-836-5501 |
| E-mail: |
-
|
| Internet: |
www.resmed.com/ |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
30/06 |
| Free Float: |
73.75% |
| IPO date: |
02/06/1995 |
Company calendar
|
CW 45 | 07/11/2024
Ex-Dividend
|
|
CW 45 | 07/11/2024
Record Date
|
|
CW 47 | 20/11/2024
General Shareholder Meeting
|
|
CW 50 | 12/12/2024
Dividend Payment
|
